Bruker (BRKR) FCF Margin Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Bruker | 8.89 Bn | 8.77 Bn | 379.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -751.00 |
| Dec 31, 2025 | -3,625.00 |
| Sep 30, 2025 | -1,896.00 |
| Jun 30, 2025 | -1,666.00 |
| Mar 31, 2025 | 381.00 |
| Dec 31, 2024 | -235.00 |
| Sep 30, 2024 | -628.00 |
| Jun 30, 2024 | -143.00 |
| Mar 31, 2024 | -72.00 |
| Dec 31, 2023 | 13.00 |
| Sep 30, 2023 | -113.00 |
| Jun 30, 2023 | -765.00 |
| Mar 31, 2023 | 94.00 |
| Dec 31, 2022 | 212.00 |
| Sep 30, 2022 | -392.00 |
| Jun 30, 2022 | -413.00 |
| Mar 31, 2022 | 440.00 |
| Dec 31, 2021 | -82.00 |
| Sep 30, 2021 | -563.00 |
| Jun 30, 2021 | -252.00 |
| Mar 31, 2021 | 1,907.00 |
| Dec 31, 2020 | -114.00 |
| Sep 30, 2020 | 139.00 |
| Jun 30, 2020 | 32.00 |
| Mar 31, 2020 | -496.00 |
| Dec 31, 2019 | 576.00 |
| Sep 30, 2019 | 609.00 |
| Jun 30, 2019 | -269.00 |
| Mar 31, 2019 | -141.00 |
| Dec 31, 2018 | -194.00 |
| Sep 30, 2018 | -300.00 |
| Jun 30, 2018 | 1,121.00 |
| Mar 31, 2018 | 1,651.00 |
| Dec 31, 2017 | 408.00 |
| Sep 30, 2017 | 1,003.00 |
| Jun 30, 2017 | -1,081.00 |
| Mar 31, 2017 | 716.00 |
| Dec 31, 2016 | 146.00 |
| Sep 30, 2016 | 420.00 |
| Jun 30, 2016 | 723.00 |
| Mar 31, 2016 | 515.00 |
| Dec 31, 2015 | 919.00 |
| Sep 30, 2015 | 1,135.00 |
| Jun 30, 2015 | -1,638.00 |
| Mar 31, 2015 | 599.00 |